tenapanor
tenapanor is listed in the FDA National Drug Code directory with 3 NDC codes. Available dosage form: tablet, film coated.
Drug details
- Generic Name
- tenapanor
- Sponsor
- Patheon Pharmaceuticals Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED
- Active Ingredients
- TENAPANOR HYDROCHLORIDE, TENAPANOR
Indications and Usage
1 INDICATIONS AND USAGE XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH is a sodium hydrogen exchanger 3 (NHE3) inhibitor indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy ( 1 ).